Complexes & Reagents
- High-purity Complexes & Reagents
- Extensive range of Complexes & Reagents
- Ideal for drug discovery applications and organic synthesis
- Fast delivery and expert support
Browse by Subcategory
Filters
Rucl[(R,R)-Tsdpen](mesitylene) 95%
RuPhos 97%
RuPhos (CAS 787618-22-8) is supplied by Activate Scientific.This Buchwald dialkylbiarylphosphine ligand features diisopropoxy substitution on the lower ring, giving palladium catalysts a steric and electronic profile well suited to challenging carbon-nitrogen bond formation. RuPhos-based Pd catalysts are effective for Buchwald-Hartwig amination of aryl and heteroaryl halides with secondary amines, anilines, and other nitrogen nucleophiles.Buy RuPhos from Activate Scientific online today. Every product in the Activate Scientific portfolio undergoes rigorous quality control testing, and our building blocks are supplied to the highest purity standards. Activate Scientific also offers custom synthesis via our quote tool.
RuPhos Pd G1 methyl tert-Butyl Ether Adduct 98%
RuPhos Pd G3 98%
RuPhos Pd G3 (CAS 1445085-77-7) is supplied by Activate Scientific.This third-generation Buchwald palladacycle precatalyst bears the RuPhos ligand on a methanesulfonate-stabilised 2-aminobiphenyl scaffold. Treatment with a mild base in the reaction solvent rapidly generates the active, monoligated RuPhos-Pd(0) species in situ, delivering the same Buchwald-Hartwig amination and Suzuki-Miyaura coupling reactivity associated with RuPhos, with the improved activation cleanliness typical of third-generation precatalyst designs.Buy RuPhos Pd G3 from Activate Scientific online today. Every product in the Activate Scientific portfolio undergoes rigorous quality control testing, and our building blocks are supplied to the highest purity standards. Activate Scientific also offers custom synthesis via our quote tool.
RuPhos Pd G4 97%
RUPHOS PD(CROTYL)CL 98%
Ruthenium(1+), bis(2,2''-bipyridine-?N1,?N1'')([2,2''-bipyridine]-4-carboxylato-?N1,?N1'')-, hydrogen chloride (1:1:2) 98%
Ruthenium(III) acetate 95%
Ruthenium(III) chloride 97%
Ruthenium(III) chloride (CAS 10049-08-8) is supplied by Activate Scientific.RuCl3 is a foundational ruthenium precursor salt used to synthesise a broad range of ruthenium catalysts, including ruthenium-arene dimers, phosphine complexes, and other well-defined species used in hydrogenation, metathesis, and photoredox catalysis.Buy Ruthenium(III) chloride (anhydrous) from Activate Scientific online today. Every product in the Activate Scientific portfolio undergoes rigorous quality control testing, and our building blocks are supplied to the highest purity standards. Activate Scientific also offers custom synthesis via our quote tool.
Ruthenium(III) chloride hydrate 97%
Ruthenium(III) chloride trihydrate 95%
Ruthenium(III) chloride trihydrate (CAS 13815-94-6) is supplied by Activate Scientific as a hydrated ruthenium(III) precursor salt.The trihydrate form offers improved solubility and easier handling in aqueous or hydrated reaction media compared with anhydrous RuCl3. It is a standard starting material for synthesising ruthenium-arene dimers (such as [RuCl2(p-cymene)]2), phosphine complexes, and other well-defined ruthenium species used across hydrogenation, olefin metathesis, and photoredox catalyst development, making it one of the most commonly stocked ruthenium sources for catalyst synthesis.Buy RuCl3·3H2O from Activate Scientific online today. Every product in the Activate Scientific portfolio undergoes rigorous quality control testing, and our building blocks are supplied to the highest purity standards. Activate Scientific also offers custom synthesis via our quote tool.
Ruthenium(IV) Oxide Hydrate 99%
Ruthenium(IV) Oxide Hydrate (CAS 32740-79-7) is supplied by Activate Scientific.This hydrated ruthenium oxide is used as an oxidation catalyst and electrocatalyst. In combination with a stoichiometric co-oxidant such as sodium periodate, ruthenium oxide-derived species generate the reactive perruthenate/ruthenium tetroxide oxidant used for oxidative alkene cleavage and dihydroxylation chemistry, and the material also finds use as an electrocatalyst in electrochemical oxidation research.Buy Ruthenium(IV) Oxide Hydrate from Activate Scientific online today. Every product in the Activate Scientific portfolio undergoes rigorous quality control testing, and our building blocks are supplied to the highest purity standards. Activate Scientific also offers custom synthesis via our quote tool.
S-PHOS 95%
SPhos (2-Dicyclohexylphosphino-2',6'-dimethoxybiphenyl, CAS 657408-07-6) is supplied by Activate Scientific as a key Buchwald-type dialkylbiarylphosphine ligand for palladium-catalyzed cross-coupling.SPhos combines a dimethoxy-substituted lower ring with a dicyclohexylphosphino donor group, a combination of steric bulk and electron density that allows Pd/SPhos catalyst systems to effect Suzuki-Miyaura coupling of hindered aryl and heteroaryl boronic acids with aryl chlorides, bromides, and aryl tosylates under mild conditions and low catalyst loading. This broad substrate scope, including electronically deactivated and sterically congested partners, was established in the ligand's original report and has since made SPhos a default screening ligand for new biaryl coupling targets. It is typically used with Pd(OAc)2 or as a preformed Pd G2/G3 precatalyst, together with a mild inorganic base (K3PO4, K2CO3) in aqueous THF, dioxane, or toluene, and has also been applied to Negishi and Buchwald-Hartwig amination chemistry.Buy SPhos from Activate Scientific online today. Every product in the Activate Scientific portfolio undergoes rigorous quality control testing, and our building blocks are supplied to the highest purity standards. Activate Scientific supplies SPhos and related Buchwald-type ligands to laboratories worldwide, and offers custom synthesis of bespoke phosphine ligands and coupling partners via our quote tool.
Sodium 2-Diphenylphosphanylethanesulfonate 80%
Sodium hexachloroplatinate(IV) hexahydrate 98%
Sodium Hexachlororhodate(III) 98%
Sodium hexahydroxyplatinate(IV) 98%
Sodium Sulphobutylether-beta-cyclodextrin 98%
Sodium Sulfobutylether-beta-cyclodextrin (CAS 182410-00-0) is supplied by Activate Scientific.This chemically modified cyclodextrin bears anionic sulfobutylether substituents that substantially improve aqueous solubility relative to the parent beta-cyclodextrin. It forms host-guest inclusion complexes with poorly water-soluble organic compounds, valuable for aqueous solubilisation, formulation, and host-guest chemistry research.Buy Sodium Sulfobutylether-beta-cyclodextrin from Activate Scientific online today. Every product in the Activate Scientific portfolio undergoes rigorous quality control testing, and our building blocks are supplied to the highest purity standards. Activate Scientific also offers custom synthesis via our quote tool.
Sodium Tetrachloropalladate(II) 98%
SPhos Pd G2 98%
SPhos Pd G3 96%
SPhos Pd G3 (CAS 1445085-82-4) is supplied by Activate Scientific.This third-generation Buchwald precatalyst combines the SPhos ligand with a palladacycle scaffold designed for rapid, clean activation into the active Pd(0)/SPhos catalytic species. Third-generation precatalysts were developed to improve solubility and activation cleanliness relative to first- and second-generation designs, and this system offers broad substrate scope in Suzuki-Miyaura coupling, particularly for challenging heteroaryl and sterically hindered partners.Buy SPhos Pd G3 from Activate Scientific online today. Every product in the Activate Scientific portfolio undergoes rigorous quality control testing, and our building blocks are supplied to the highest purity standards. Activate Scientific also offers custom synthesis via our quote tool.
t-BuBrettPhos Pd 97%
t-Butyl-Xantphos 97%
TATU 98%
TATU (CAS 873798-09-5) is supplied by Activate Scientific.This uronium-type peptide coupling reagent, related to the HATU/azabenzotriazole family, efficiently activates carboxylic acids for amide bond formation with amines, offering fast coupling kinetics and low racemisation.Buy TATU from Activate Scientific online today. Every product in the Activate Scientific portfolio undergoes rigorous quality control testing, and our building blocks are supplied to the highest purity standards. Activate Scientific also offers custom synthesis via our quote tool.
Understanding Complexes & Reagents in Modern Chemistry
Explore the critical role of Complexes & Reagents in pharmaceutical development, medicinal chemistry research and organic chemistry.
Precision Chemistry
Advanced synthesis techniques for superior quality compounds
Great Molecules for Chemical Diversity
Our catalogue of building blocks contains a diverse range of highly functionalised and decorated compounds. The 20 years of experience in supplying cutting-edge building blocks have given us the expertise to bring you the most exciting chemical motifs, adding chemical diversity to your projects.
Our diverse catalogue is tailored for medicinal chemistry, small molecule drug discovery and organic synthesis. Our unique range of Complexes & Reagents adds value to any research project.
We constantly add to our catalogue; the latest additions include a range of new Complexes & Reagents. We continue to bring you the latest and most exciting chemical compounds.
Quality Assurance
Every Complexes & Reagents product in our portfolio undergoes rigorous quality control testing. Our building blocks are supplied with the highest purity standards. We provide complete analytical characterisation, including:
- ¹H and ¹³C NMR spectroscopy for structural verification
- HPLC chromatograms confirming purity levels
- Certificate of Analysis available.
- Standard purity of 95%
- Specific purity available upon request.
Diverse Applications
From oncology to neuroscience, enabling next-generation therapeutics
Complexes & Reagents products in our portfolio
Reagents and metal complexes are the enabling tools of synthetic medicinal chemistry, determining whether a desired bond can be formed efficiently, selectively, and at a scale compatible with drug discovery programmes. The most widely used reactions in small-molecule drug synthesis, including amide coupling, palladium-catalysed cross-coupling, reductive amination, asymmetric reduction, and olefin metathesis, each depend on a distinct set of reagents and catalyst complexes that have been refined over decades to maximise chemoselectivity, functional group tolerance, and operational simplicity. The Suzuki-Miyaura and Buchwald-Hartwig methodologies are the two most common coupling reactions in medicinal chemistry, valued for their versatility in generating carbon-carbon and carbon-heteroatom bonds across diverse substrates, with the Suzuki-Miyaura coupling also used in the large-scale synthesis of approved drugs including losartan and abemaciclib. Amide bond formation, present in the majority of top-selling small-molecule drugs, relies on uronium and phosphonium-based coupling reagents, most notably HATU, HBTU, PyBOP, and EDC, used together with HOBt or HOAt as racemisation-suppressing additives and a tertiary amine base. Asymmetric synthesis of chiral drug candidates is enabled by the Noyori BINAP-Ru complexes and related chiral bisphosphine-metal systems that deliver ketone hydrogenation with high enantioselectivity, while Grubbs and Hoveyda-Grubbs ruthenium carbene catalysts provide access to macrocyclic and ring-closing metathesis products in complex natural product-derived drug scaffolds. The emergence of photoredox and electrochemical synthesis has introduced an entirely new class of reagents and catalytic systems, including iridium polypyridyl complexes, ruthenium bipyridyl complexes, metal-free organic dyes, and electrode-based oxidants, which access radical intermediates and redox-activated bond formations inaccessible by thermal methods. Together, these reagents and complexes define the synthetic toolbox available to the medicinal chemist and set the boundaries of what chemical space can be rapidly and reliably explored in a drug discovery campaign.
Reagents and complexes in common organic chemistry reactions
The most frequently employed reagents in medicinal chemistry synthesis fall
into several well-defined categories corresponding to the reactions they
enable. For amide bond formation, the single most common transformation in
drug synthesis, the key reagents are carbodiimide activators (DCC, DIC, EDC)
and the more reactive uronium and phosphonium coupling salts. The most common
syntheses of amides use stoichiometric quantities of activating agents such
as DCC, DIC, and EDC, and coupling via guanidinium and uronium salts such as
HATU, HBTU, TBTU, CDI, and T3P. HATU provides faster and more efficient
couplings with less epimerisation and under milder reaction conditions than
its structural analogue HBTU, attributed to the formation of a stabilising
hydrogen bond in the reaction intermediate, making it the reagent of choice
for difficult or sterically hindered couplings. For palladium-catalysed
cross-coupling, the choice of palladium precatalyst and phosphine or
N-heterocyclic carbene (NHC) ligand is critical. The most widely used
palladium sources are Pd(OAc)₂ and Pd₂(dba)₃, paired with biarylphosphine
ligands including SPhos, RuPhos, and XPhos developed by the Buchwald group,
or with NHC-ligated PEPPSI-type complexes. Whether one uses Pd₂(dba)₃ or
Pd(OAc)₂ as a precatalyst can have a profound effect on the success of any
given transformation, with dba playing an active role as a ligand in
controlling the rates of oxidative addition as well as the concentration of
catalytically active species. NHC ligands, particularly IPr and IMes, offer
strong σ-donation and steric shielding that stabilise coordinatively
unsaturated palladium species and enable coupling of challenging
electrophiles including aryl chlorides and sterically hindered substrates.
NHC complexes are easily obtained by deprotonating imidazolium or
benzimidazolium salts and are relatively stable to air and moisture; they are
weak π-acceptors and strong σ-donors that form strong M-C bonds with
transition metal ions compared to trivalent phosphine ligands. For reductive
amination, the most common hydride reductants are sodium cyanoborohydride
(NaBH₃CN) and sodium triacetoxyborohydride (NaBH(OAc)₃), both of which
selectively reduce iminium ions in the presence of the unreacted aldehyde and
other functional groups. The Dess-Martin periodinane (DMP) and Swern
conditions (oxalyl chloride/DMSO/Et₃N) provide mild, selective alcohol
oxidation to aldehydes and ketones, while the Grubbs second-generation
catalyst, a ruthenium benzylidene complex bearing an NHC ligand and a
tricyclohexylphosphine, performs ring-closing metathesis with excellent
functional group tolerance across a wide range of drug-like substrates.
Reagents and complexes in emerging photochemistry and electrochemistry
The development of photoredox catalysis and electrochemical synthesis has
introduced a new generation of reagents and catalytic complexes that operate
through single-electron transfer (SET) rather than the two-electron polar
mechanisms of classical organic chemistry. The triplet state of fac-Ir(ppy)₃
lies 56 kcal mol⁻¹ above the ground state, giving this iridium(III)
tris(phenylpyridine) complex a capacity to act simultaneously as both an
oxidant and a reductant in its excited state; this unique property enables a
wide array of novel synthetic transformations and provides access to
previously elusive mechanistic pathways. The ruthenium complex [Ru(bpy)₃]²⁺
was among the earliest photoredox catalysts applied to preparative organic
synthesis, enabling enantioselective α-alkylation of aldehydes in combination
with chiral imidazolidinone organocatalysts, establishing the principle of
dual photoredox/organocatalysis. Metal-free organic dyes, including eosin Y,
rose bengal, acridinium salts, and the carbazole-based 4CzIPN, have emerged
as cost-effective and structurally tunable alternatives to iridium and
ruthenium complexes, with their ground and excited-state redox potentials
readily modulated by substitution of the core chromophore. Nickel/photoredox
dual catalysis is efficacious in activating inert bonds and creating reaction
pathways not achievable under single-catalyst conditions; the single-electron
transfer processes and versatile oxidation states of nickel, coupled with
organic and metal-based photocatalysts, underpin dual catalytic cycles that
enable enantioselective C-N and C-O coupling reactions and C(sp²)-C(sp³) bond
construction. In practice, Ni(cod)₂ or NiCl₂(dme) paired with dtbbpy or
bipyridyl ligands constitutes the nickel component of these dual systems,
with the photocatalyst typically used at sub-stoichiometric loading of 1-5
mol%. Electrochemical synthesis replaces stoichiometric chemical oxidants and
reductants with controlled electrode potential, eliminating reagent waste and
enabling reactions at a continuously tuneable potential. Electrosynthetic
methods, which obviate the need for hazardous chemical oxidants or
reductants, offer unprecedented control of reactions through the continuous
variation of applied potential; this capability is particularly advantageous
for late-stage functionalisation of drug candidates, where chemoselectivity
over multiple sensitive functional groups is essential. The key
electrochemical reagents include conducting electrolytes, most commonly
tetrabutylammonium tetrafluoroborate (Bu₄NBF₄) or hexafluorophosphate salts
dissolved in DMF, MeCN, or MeOH, which carry current through the cell without
participating in the substrate reaction. Selectfluor serves a dual role in
electrochemical C-H fluorination, functioning both as the electrophilic
fluorine source and as a redox mediator through its reducible N-F bond,
enabling selective fluorination of unactivated C(sp³)-H bonds that cannot be
achieved by classical electrophilic methods. Hypervalent iodine reagents,
including PhI(OAc)₂ and its cyclic variants such as the Koser reagent and
Togni reagents, can be generated electrochemically in situ from aryl iodides,
providing an oxidant-free approach to α-oxygenation, trifluoromethylation,
and C-H acetamidation, transformations that install or modify functional
groups present across a wide range of drug scaffolds.
Frequently Asked Questions
Common questions about our Complexes & Reagents products.
Still have questions?
Our technical support team is here to help with any inquiries about our Complexes & Reagents products.